In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

At JPMorgan XXIV: Mostly Pharma but Little Strategic Agreement

Executive Summary

The diversity of messages from the Big Pharma presenters at this important conference reflected the broader investment uncertainty about the sector. Investors weren't certain about the biotech business model either, though they packed the rooms. Among the basic arguments: whether the returns from companies pursuing compounds against novel targets will trump the returns from those companies pursuing precedented mechanisms.
Advertisement

Related Content

Overheard at JP Morgan's 25th Health Care Conference: Making Up for Lost Drugs: Pharma Attempts to Appease Investors
Hep C Development Dilemma: Big Money Now or Bigger Money Later?
Hep C Development Dilemma: Big Money Now or Bigger Money Later?
The Buzz at JP Morgan--Devices: No Longer the Conference Stepchild
The Buzz at JP Morgan--Biopharma: New Models Wanted
Roche's Partners: Replacing, or Fuelling In-House R&D?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002707

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel